BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 7124564)

  • 1. Effects of ascorbic acid on neutrophil function. Studies on normal and chronic granulomatous disease neutrophils.
    Patrone F; Dallegri F; Bonvini E; Minervini F; Sacchetti C
    Acta Vitaminol Enzymol; 1982; 4(1-2):163-8. PubMed ID: 7124564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of antibody-dependent cellular cytotoxicity: the use of effector cells from chronic granulomatous disease patients as investigative probes.
    Katz P; Simone CB; Henkart PA; Fauci AS
    J Clin Invest; 1980 Jan; 65(1):55-63. PubMed ID: 6243141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ascorbic acid, neutrophil function, and the immune response.
    Leibovitz B; Siegel BV
    Int J Vitam Nutr Res; 1978; 48(2):159-64. PubMed ID: 357320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo effect of ascorbic acid on neutrophil function in healthy and dexamethasone-treated cattle.
    Roth JA; Kaeberle ML
    Am J Vet Res; 1985 Dec; 46(12):2434-6. PubMed ID: 4083574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of ascorbate on leucocytes: Part IV. Increased neutrophil function and clinical improvement after oral ascorbate in 2 patients with chronic granulomatous disease.
    Anderson R; Dittrich OC
    S Afr Med J; 1979 Sep; 56(12):476-80. PubMed ID: 550375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of oxygen in antibody-dependent cytotoxicity mediated by monocytes and neutrophils.
    Borregaard N; Kragballe K
    J Clin Invest; 1980 Oct; 66(4):676-83. PubMed ID: 6252248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of oral ascorbate in three children with chronic granulomatous disease and defective neutrophil motility over a 2-year period.
    Anderson R
    Clin Exp Immunol; 1981 Jan; 43(1):180-8. PubMed ID: 6265123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulation of innate immune receptors on neutrophils in chronic granulomatous disease.
    Hartl D; Lehmann N; Hoffmann F; Jansson A; Hector A; Notheis G; Roos D; Belohradsky BH; Wintergerst U
    J Allergy Clin Immunol; 2008 Feb; 121(2):375-382.e9. PubMed ID: 18155283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the oxidative metabolic burst in the antibody-dependent cellular cytotoxicity mediated by neutrophil polymorphonuclears.
    Dallegri F; Frumento G; Minervini F; Muttini P; Patrone F
    Exp Hematol; 1982 Nov; 10(10):859-66. PubMed ID: 6295791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of chemotactic factors and agents which influence neutrophil movement on anaerobic glycolysis and hexose monophosphate shunt activity.
    Anderson R; Glover A; Rabson AR
    Immunology; 1978 Jul; 35(1):141-9. PubMed ID: 680798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PHA-induced neutrophil-mediated cytotoxicity.
    Dallegri F; Frumento G; Maggi A; Patrone F
    J Clin Lab Immunol; 1983 Aug; 11(4):203-6. PubMed ID: 6199502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil-mediated antibody-dependent cellular cytotoxicity against erythrocytes. Mechanisms of target cell destruction.
    Dallegri F; Patrone F; Holm G; Gahrton G; Sacchetti C
    Clin Exp Immunol; 1983 Jun; 52(3):613-9. PubMed ID: 6307559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bactericidal activity of human neutrophil granulocytes. Studies in clinical disorders with the in vitro bactericidal test.
    Koch C
    Acta Pathol Microbiol Scand Suppl; 1978; (266):1-63. PubMed ID: 208349
    [No Abstract]   [Full Text] [Related]  

  • 14. Ascorbate (1g/day) does not help the phagocyte killing defect of X-linked chronic granulomatous disease.
    Foroozanfar N; Lucas CF; Joss DV; Hugh-Jones K; Hobbs JR
    Clin Exp Immunol; 1983 Jan; 51(1):99-102. PubMed ID: 6339127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of random migration and chemotactic response of human leukocytes by ascorbic acid.
    Goetzl EJ; Wasserman SI; Gigli I; Austen KF
    J Clin Invest; 1974 Mar; 53(3):813-8. PubMed ID: 4273024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amantadine in chronic granulomatous disease.
    Granzotto M; Leone V; Lepore L; Zerial M; Tommasini A; Ciambra R; Gombac F; Ventura A
    Pediatr Hematol Oncol; 2005 Mar; 22(2):147-51. PubMed ID: 15805000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short communication. Glycogenosis Ib: neutrophil microbicidal defects due to impaired hexose monophosphate shunt.
    Seger R; Steinmann B; Tiefenauer L; Matsunaga T; Gitzelmann R
    Pediatr Res; 1984 Mar; 18(3):297-9. PubMed ID: 6328404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vitamin C and phagocytic system: present status and perspectives (author's transl)].
    Patrone F; Dallegri F
    Acta Vitaminol Enzymol; 1979; 1(1-6):5-10. PubMed ID: 400272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Killing of pathogens associated with chronic granulomatous disease by the non-oxidative microbicidal mechanisms of human neutrophils.
    Odell EW; Segal AW
    J Med Microbiol; 1991 Mar; 34(3):129-35. PubMed ID: 2010902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic granulomatous disease in a 23-year-old female.
    Capsoni F; Minonzio F; Venegoni E; Lazzarin A; Galli M; Silvani C; Ongari AM; Zanussi C
    J Clin Lab Immunol; 1986 Mar; 19(3):149-54. PubMed ID: 3712419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.